China Sky One Medical, Inc. Announces Its Successful Participation in the 20th International Medical Instruments and Equipment Exhibition

HARBIN, China, April 16 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (“China Sky One Medical” or “the Company”) (OTC Bulletin Board: CSKI), a leading manufacturer, marketer, and distributor of

over-the-counter pharmaceuticals for external use in the People’s Republic of China (“PRC”) and international markets, today announced its successful participation in the 20th International Medical Instruments and Equipment Exhibition, which was held in Beijing, China from April 3rd to April 5th 2008.

The International Exhibition, well recognized throughout the industry, has been held for 20 consecutive years with over 600 vendors from about 20 countries. The 2008 Exhibition attracted more than 30,000 visitors from around the world.

This was the third year China Sky One Medical participated in the Exhibition. The Company sponsored a booth at the show for healthcare products & diagnostic kits and was exposed to 150 international distributors, many of whom expressed a strong interest in the Company’s products. Its Slim Patch Body-Beauty Plaster product gained significant attention due to its revolutionary technique to reduce weight compared to competitors’ products. Two companies, one from Russia and one from the UK expressed their interest in becoming distributors for the Slim Patch Body-Beauty Plaster product and Diagnostic Kits, and are now in discussions with the Company regarding future cooperation and marketing agreements.

“We are excited about the high reception of our products at the exhibition, a good demonstration of our strong brand recognition and product popularity. We intend to continue with our strategy to focus on sales and marketing to increase our international customer base,” said Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical, Inc.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR") and Harbin First

Bio-Engineering Company Limited ("First"), the Company manufactures and distributes over-the-counter pharmaceutical products as its primary revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute

forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People’s Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

For more information, please contact:

China Sky One Medical, Inc.

Ms. Xiaoyan Han, CFO

Tel: +86-1335-999-3681

Email: tdrhan@163.com

CCG Elite Investor Relations Inc.

Mr. Crocker Coulson, President

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com